INO80
Chromatin-remodeling ATPase INO80
Also known as: hINO80, INO80_HUMAN, INO80A, INOC1, KIAA1259
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULG1
- Gene
- INO80
- Ensembl
- ENSG00000128908
- Chromosome
- 15
- Canonical length
- 1556 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
This gene encodes a subunit of the chromatin remodeling complex, which is classified into subfamilies depending on sequence features apart from the conserved ATPase domain. This protein is the catalytic ATPase subunit of the INO80 chromatin remodeling complex, which is characterized by a DNA-binding domain. This protein is proposed to bind DNA and be recruited by the YY1 transcription factor to activate certain genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
1556 residues, UniProt reviewed canonical sequence.
>Q9ULG1|INO80
1 MASELGARDD GGCTELAKPL YLQYLERALR LDHFLRQTSA IFNRNISSDD SEDGLDDSNP
61 LLPQSGDPLI QVKEEPPNSL LGETSGAGSS GMLNTYSLNG VLQSESKCDK GNLYNFSKLK
121 KSRKWLKSIL LSDESSEADS QSEDDDEEEL NLSREELHNM LRLHKYKKLH QNKYSKDKEL
181 QQYQYYSAGL LSTYDPFYEQ QRHLLGPKKK KFKEEKKLKA KLKKVKKKRR RDEELSSEES
241 PRRHHHQTKV FAKFSHDAPP PGTKKKHLSI EQLNARRRKV WLSIVKKELP KANKQKASAR
301 NLFLTNSRKL AHQCMKEVRR AALQAQKNCK ETLPRARRLT KEMLLYWKKY EKVEKEHRKR
361 AEKEALEQRK LDEEMREAKR QQRKLNFLIT QTELYAHFMS RKRDMGHDGI QEEILRKLED
421 SSTQRQIDIG GGVVVNITQE DYDSNHFKAQ ALKNAENAYH IHQARTRSFD EDAKESRAAA
481 LRAANKSGTG FGESYSLANP SIRAGEDIPQ PTIFNGKLKG YQLKGMNWLA NLYEQGINGI
541 LADEMGLGKT VQSIALLAHL AERENIWGPF LIISPASTLN NWHQEFTRFV PKFKVLPYWG
601 NPHDRKVIRR FWSQKTLYTQ DAPFHVVITS YQLVVQDVKY FQRVKWQYMV LDEAQALKSS
661 SSVRWKILLQ FQCRNRLLLT GTPIQNTMAE LWALLHFIMP TLFDSHEEFN EWFSKDIESH
721 AENKSAIDEN QLSRLHMILK PFMLRRIKKD VENELSDKIE ILMYCQLTSR QKLLYQALKN
781 KISIEDLLQS SMGSTQQAQN TTSSLMNLVM QFRKVCNHPE LFERQETWSP FHISLKPYHI
841 SKFIYRHGQI RVFNHSRDRW LRVLSPFAPD YIQRSLFHRK GINEESCFSF LRFIDISPAE
901 MANLMLQGLL ARWLALFLSL KASYRLHQLR SWGAPEGESH QRYLRNKDFL LGVNFPLSFP
961 NLCSCPLLKS LVFSSHCKAV SGYSDQVVHQ RRSATSSLRR CLLTELPSFL CVASPRVTAV
1021 PLDSYCNDRS AEYERRVLKE GGSLAAKQCL LNGAPELAAD WLNRRSQFFP EPAGGLWSIR
1081 PQNGWSFIRI PGKESLITDS GKLYALDVLL TRLKSQGHRV LIYSQMTRMI DLLEEYMVYR
1141 KHTYMRLDGS SKISERRDMV ADFQNRNDIF VFLLSTRAGG LGINLTAADT VIFYDSDWNP
1201 TVDQQAMDRA HRLGQTKQVT VYRLICKGTI EERILQRAKE KSEIQRMVIS GGNFKPDTLK
1261 PKEVVSLLLD DEELEKKLRL RQEEKRQQEE TNRVKERKRK REKYAEKKKK EDELDGKRRK
1321 EGVNLVIPFV PSADNSNLSA DGDDSFISVD SAMPSPFSEI SISSELHTGS IPLDESSSDM
1381 LVIVDDPASS APQSRATNSP ASITGSVSDT VNGISIQEMP AAGRGHSARS RGRPKGSGST
1441 AKGAGKGRSR KSTAGSAAAM AGAKAGAAAA SAAAYAAYGY NVSKGISASS PLQTSLVRPA
1501 GLADFGPSSA SSPLSSPLSK GNNVPGNPKN LHMTSSLAPD SLVRKQGKGT NPSGGRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against INO80 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 12 nTPM
- tonsil: 9.2 nTPM
- thymus: 9.1 nTPM
- parathyroid gland: 8.7 nTPM
- tongue: 8.3 nTPM
- lung: 8.2 nTPM
Single-cell type
- epicardial cells: 3,548 nCPM
- myonuclei: 271 nCPM
- alveolar cells type 2: 148 nCPM
- endometrial glandular cells: 141 nCPM
- mesothelial cells: 141 nCPM
- syncytiotrophoblasts: 138 nCPM
Immune cell
- NK-cell: 0.9 nTPM
- classical monocyte: 0.4 nTPM
- gdT-cell: 0.4 nTPM
- MAIT T-cell: 0.4 nTPM
- naive B-cell: 0.4 nTPM
- naive CD4 T-cell: 0.4 nTPM
Brain region
- cerebellum: 17 nTPM
- white matter: 14 nTPM
- medulla oblongata: 13 nTPM
- thalamus: 13 nTPM
- basal ganglia: 12 nTPM
- cerebral cortex: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about INO80.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 242 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Primary microcephaly
- Seizure
- Intellectual disability
- INO80-related immunodeficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.08
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.53
- DepMap mean gene effect
- -0.88
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- cellular response to ionizing radiation
- cellular response to UV
- chromatin remodeling
- DNA repair
- DNA-templated transcription
- double-strand break repair
- double-strand break repair via homologous recombination
- mitotic sister chromatid segregation
- positive regulation of cell growth
- positive regulation of DNA repair
- positive regulation of DNA-templated transcription
- positive regulation of nuclear cell cycle DNA replication
- positive regulation of telomere maintenance in response to DNA damage
- positive regulation of transcription by RNA polymerase II
- regulation of cell cycle
- regulation of chromosome organization
- regulation of DNA repair
- regulation of DNA replication
- regulation of DNA strand elongation
- regulation of embryonic development
- regulation of G1/S transition of mitotic cell cycle
- spindle assembly
- telomere maintenance
- UV-damage excision repair
Molecular functions
- actin binding
- alpha-tubulin binding
- ATP binding
- ATP hydrolysis activity
- ATP-dependent activity, acting on DNA
- ATP-dependent chromatin remodeler activity
- DNA binding
- histone binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SNF2, N-terminal domain
- Helicase, C-terminal domain-like
- Helicase superfamily 1/2, ATP-binding domain
- P-loop containing nucleoside triphosphate hydrolase
- SNF2-like, N-terminal domain superfamily
- SNF2/RAD5-like, C-terminal helicase domain
- INO80/SWR1 chromatin remodeling helicase
- SNF2-related domain
- Helicase conserved C-terminal domain
- DBINO domain
- DNA helicase INO80, DEAQ-box helicase domain
- DNA-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of INO80 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads INO80 as an antibody target. Whether an autoantibody or antibody against INO80 could matter depends on whether native INO80 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
INO80 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label INO80 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...